Hyperinsulinism: Clinical Trials

40 trials for Hyperinsulinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 unknown. 40 Phase 2, 8 Phase 3, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 240Unknown 40
Phase 38Unknown 8
Phase 17Unknown 7

Follow Hyperinsulinism: new trials by email Literature Review of Hyperinsulinism trials Research Report on Hyperinsulinism

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system - type1diabetes, Diabetes Mellitus, Type 1
Phase 2 / Phase 3UnknownMcGill University Health Centre/Research Institute of the McGill University Health Centre302023-11-302024-04-18
Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus
Capsules containing the combination products, Placebo capsules - Type 2 Diabetes
Phase 1 / Phase 2UnknownTabriz University of Medical Sciences602023-07-282023-04-14
Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals
6-BT, Placebo - Metabolic Syndrome, Diabetes Mellitus
Phase 1 / Phase 2UnknownNordin Hanssen362023-05-042023-08-22
A Study Evaluating Daily Oral Doses of TLC-3595 in Participants With Insulin Resistance
TLC-3595 Dose 1, TLC-3595 Dose 2, Placebo - Insulin Resistance
Phase 2UnknownOrsoBio, Inc762023-03-082024-08-20
KurCoSmart Effects on People With Type 2 DM
Curcumin and virgin coconut oil extract (KurCo Smart) - Diabetes Mellitus, Type 2, Insulin Resistance
Phase 1 / Phase 2UnknownUniversitas Sebelas Maret402022-06-012022-06-07
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome
β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group, Placebo Group - Cardiometabolic Syndrome
Phase 2UnknownUniversity of Brawijaya702021-06-302021-10-15
Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose
Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg - Impaired Glucose Tolerance, Insulin Sensitivity
Phase 2UnknownOslo University Hospital642021-02-102021-04-08
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment
Phase 2 / Phase 3UnknownJaime Daniel Mondragon2702020-08-012022-10-04
Effects of Exercise During the Acute Phase of Burns
Exercise, Standard of Care - Burns
Phase 2UnknownUniversiteit Antwerpen402020-05-042020-08-14
Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
Ellagic Acid / Pomegranate Extract, Placebo oral capsule - Metabolic Syndrome
Phase 2UnknownUniversity of Guadalajara322019-09-172022-06-15
Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels
Combination of a plant extract (BSL_EP044) and Lactobacillus BSL_PS6, Placebo - Polycystic Ovarian Syndrome, Insulin Resistance
Phase 1 / Phase 2UnknownBiosearch S.A.342019-05-292020-07-10
The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.
Glycine - Metabolic Syndrome, Dyslipidemias
Phase 2 / Phase 3UnknownProf. Tony hayek MD502019-03-012019-02-21
Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols
Olive polyphenols, Control - Cholesterol; Metabolic Disorder, Metabolic Syndrome
Phase 2UnknownUniversidad Miguel Hernandez de Elche602018-06-012018-07-12
Stem Cell Educator Therapy in Diabetes
Stem Cell Educator therapy - Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Phase 2UnknownThrone Biotechnologies Inc.1002017-11-272019-02-05
The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome
Folic Acid - Polycystic Ovary Syndrome
Phase 1 / Phase 2UnknownUniversity of Khartoum902017-09-012017-08-31
The Effects of Butyrate on Children With Obesity
Butyrate, Placebo - Insulin Resistance, Obesity
Phase 2 / Phase 3UnknownFederico II University402016-03-012016-03-30
Non-surgical Periodontal Therapy and Myo-inositol in Polycystic Ovary Syndrome Women Having Chronic Periodontitis
scaling and root planing , Myo-inositol, Myo-inositol - Polycystic Ovary Syndrome, Periodontitis
Phase 2UnknownPostgraduate Institute of Dental Sciences Rohtak562015-05-012015-12-17
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
ARA 290 - Diabetes Type 2, Impaired Glucose Tolerance
Phase 2UnknownClaes-Göran Östenson242013-10-012015-09-03
Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
Diacerein, Placebo - Diabetes-Related Complications, Diabetes Mellitus, Type 2
Phase 2UnknownUniversity of Campinas, Brazil602013-01-012015-09-17
Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome
myo-inositol, Metformin - Metabolic Syndrome
Phase 2UnknownUniversity of Messina1002013-01-012014-05-20

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

Insulin Resistance (32)  ·  Diabetes Mellitus, Type 2 (12)  ·  Metabolic Syndrome (10)  ·  Diabetes Mellitus (8)  ·  Inflammation (6)  ·  Diabetes Mellitus, Type 1 (4)  ·  Glucose Intolerance (4)  ·  Obesity (3)  ·  Polycystic Ovary Syndrome (3)  ·  Critical Illness (2)  ·  Dyslipidemias (2)  ·  Hyperglycemia (2)  ·  Motor Activity (2)  ·  Muscular Atrophy (2)  ·  Vitamin D Deficiency (2)

Broader conditions

Nutritional and Metabolic Diseases (40)  ·  Glucose Metabolism Disorders (39)  ·  Metabolic Diseases (39)  ·  Endocrine System Diseases (21)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Diabetes Mellitus (10)  ·  Pathologic Processes (10)  ·  Insulin Resistance (8)  ·  Signs and Symptoms (7)  ·  Nutrition Disorders (6)  ·  Cardiovascular Diseases (5)  ·  Immune System Diseases (5)  ·  Urogenital Diseases (5)  ·  Vascular Diseases (5)

Interventions

Metformin (5)  ·  Biguanides (2)  ·  Cholecalciferol (2)  ·  Inositol (2)  ·  Interleukin 1 Receptor Antagonist Protein (2)  ·  Thiazolidinediones (2)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Bromocriptine (1)  ·  Butyrates (1)  ·  Cardiovascular Agents (1)  ·  Clopidogrel (1)  ·  Curcumin (1)  ·  Drug Delivery Systems (1)  ·  Ellagic Acid (1)

Sponsors

Radboud University Medical Center (3)  ·  Intermountain Health Care, Inc. (2)  ·  Massachusetts General Hospital (2)  ·  All India Institute of Medical Sciences (1)  ·  Baltimore VA Medical Center (1)  ·  Biosearch S.A. (1)  ·  Brooke Army Medical Center (1)  ·  Claes-Göran Östenson (1)  ·  Dow University of Health Sciences (1)  ·  Federico II University (1)  ·  German Diabetes Center (1)  ·  Jaime Daniel Mondragon (1)  ·  Kaohsiung Veterans General Hospital. (1)  ·  Limerick BioPharma (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Countries

United States (8)  ·  Netherlands (4)  ·  Italy (3)  ·  China (2)  ·  Indonesia (2)  ·  Mexico (2)  ·  Norway (2)  ·  Spain (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Denmark (1)  ·  Germany (1)  ·  India (1)

Top investigators

Alan H Morris, MD (2)  ·  Ahmad Haidar, Ph.D. (1)  ·  C J Tack, Prof Dr (1)  ·  Cees J Tack, MD PhD (1)  ·  Claudio Mizon, MD (1)  ·  Dawn M Torres, MD (1)  ·  Dr. Mario JA Saad, MD PhD (1)

Results publications

PMID 20204386, PMID 21346065, PMID 21508140, PMID 22233865, PMID 22302620, PMID 22933432, PMID 23040716, PMID 23837842, PMID 25136585, PMID 25651730, PMID 25874236, PMID 26084343, PMID 26131326, PMID 26844283, PMID 28095900, PMID 28468770, PMID 28685960, PMID 28950419, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29573529, PMID 31236801, PMID 31248555, PMID 31535829, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33894597, PMID 34813630

NIH funding

R01HD068712 (1), R21DK084527 (1)